Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 23, 2019
Pharmacy Choice - News - Over-the-Counter Drugs - March 23, 2019

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/30/17 - Here is a roundup of news items from Wayne and Pike counties
Here is a roundup of news items from Wayne and Pike counties, Pennsylvania that were covered by The News Eagle in 2017. The business opened at the former Arby's restaurant location outside Hawley, in August. 7- First baby born at Wayne Memorial Hospital in 2017 was Greyson Derrick of Hawley, born January 1st.
12/30/17 - Nutra Pharma Letter to Shareholders [Gulf Daily News (Bahrain)]
-Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis, Human Immunodeficiency Virus, Adrenomyeloneuropathy and Pain, announced today that the Company`s Chief Executive Officer, Rik J Deitsch, has published
12/30/17 - WAYNE & PIKE Year in Review: Local headlines from 2017
Here is a roundup of news items from Wayne and Pike counties, Pennsylvania that were covered by The News Eagle in 2017. The business opened at the former Arby's restaurant location outside Hawley, in August. 7- First baby born at Wayne Memorial Hospital in 2017 was Greyson Derrick of Hawley, born January 1st.
12/29/17 - Forecast and Analysis on Ethical Pharmaceuticals Market for Period 2014 - 2020
Albany, NY 12/29/2017 Ethical pharmaceuticals or prescription drugs are those licensed drugs that are regulated by various legislations to require a written medical prescription before it can be procured. According to the American Cancer Society, in 2013, approximately 1,660, 290 new cases of cancer were identified and diagnosed in the U.S. A
12/29/17 - Mallinckrodt to Acquire Sucampo Pharmaceuticals for Approximately $1.2 Billion
STAINES-UPON-THAMES, United Kingdom and ROCKVILLE, Md.- Mallinckrodt plc, a leading global specialty pharmaceutical company, and Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, today announced that they have entered into an agreement under which Mallinckrodt will acquire Sucampo, including its commercial and development assets.
12/29/17 - Nutra Pharma Letter to Shareholders
Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away? in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis, Human Immunodeficiency Virus, Adrenomyeloneuropathy and Pain, announced today that the Company's Chief Executive Officer, Rik J Deitsch, has pub
12/28/17 - Bausch + Lomb Receives FDA Approval of LUMIFY - The Only Over-The-Counter Eye Drop with Low-Dose Brimonidine for the Treatment of Eye Redness
LAVAL, Quebec- Bausch+ Lomb, a leading global eye health company and wholly owned subsidiary of Valeant Pharmaceuticals International, Inc., today announced that the U.S. Food and Drug Administration has approved LUMIFY as the first and only over-the-counter eye drop developed with low-dose brimonidine tartrate for the treatment of ocular redness.
12/28/17 - Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer [Palestine News Agency (WAFA)]
-Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel small molecule medicines to treat rare and ultra-rare genetic diseases caused by nonsense mutations today announced that Robert Ward has been appointed Chairman of the Board of Directors of Eloxx and Chief Executive Officer effective immediately.
12/28/17 - NetworkNewsBreaks Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Subsidiary Receives Dealer License from Health Canada
Emerging-stage pharmaceutical and IP development company Veritas Pharma Inc. this morning announced that Health Canada has issued its research and development subsidiary, Cannevert Therapeutics Ltd., a dealer license allowing it to possess, analyze, sale, send, transport and deliver cannabis, hemp and related products. Per the release, reception of
12/28/17 - World over the Counter (OTC) Drugs & Dietary Supplements Market : Forecast, Financial Plan and Manufacturers 2017 to : Global Market report from QY Market Research on Over the Counter Drugs & Dietary Supplements Market Professional Survey Market 2017
Deerfield Beach, FL 12/28/2017 The market report, entitled Over the Counter Drugs& Dietary Supplements Market, is an exploratory study performed by QY Market Research for the Over the Counter Drugs& Dietary Supplements market, which scrutinizes the competitive structure of the Over the Counter Drugs& Dietary Supplements industry across the wo
12/27/17 - Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer
Mr. Ward brings to Eloxx more than 30 years of experience as a global biopharmaceutical industry leader with experience across the full spectrum of drug development, commercialization, and strategic business development transactions. Mr. Ward most recently was the President and Chief Executive Officer of Radius Health, Inc.. Today the Company is po
12/27/17 - Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer: Biopharmaceutical Industry Leader with Extensive Experience In Drug Development, Strategic Business Combinations and Commercialization to Lead The Company's Strategy, Vi
Bob succeeds outgoing Chairman of the Board, Robert Heft, and current founder and Chief Executive Officer Dr. Mr. Ward brings to Eloxx more than 30 years of experience as a global biopharmaceutical industry leader with experience across the full spectrum of drug development, commercialization, and strategic business development transactions.
12/27/17 - Global OTC Consumer Health Products (Powder Form) Market Reaching a Valuation of US$40.6 Bn During 2017-2025
Albany, NY 12/27/2017 OTC consumer health products include the OTC pharmaceutical products which can be defined as the drugs which can be purchased by the customers without the physician's prescription. In addition, OTC consumer health products include nutritional supplements and sports nutrition products, among others. Global OTC Consumer He
12/27/17 - Key Projections from Fact.MR's OTC Vitamins and Dietary Supplements Market Forecast: As per the latest report published by Fact.MR, the global OTC vitamins and dietary supplements market is poised to increase at a CAGR of 6.7% between 2017 and 2022.
Rockville, MD 12/27/2017 According to the recently conducted study by Fact.MR, the global OTC vitamins and dietary supplements market is set to expand at 6.7% CAGR during the forecast period to surpass a valuation of US$ 97,688 Mn. OTC vitamin and dietary supplement products. Sales of such products have also increased in emerging countries su
12/27/17 - Sharing the Season 2017
Rowan County is home to hundreds of organizations and nonprofit groups that rely on others to help them continue their circle of giving. 1930 W. Jake Alexander Blvd., Salisbury, NC 28147. Disaster clients could use comforters and quilts of all sizes, new stuffed animals, small packs of crayons and coloring book sets, men's and women's toiletry item
12/27/17 - UPDATE Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer
Mr. Ward brings to Eloxx more than 30 years of experience as a global biopharmaceutical industry leader with experience across the full spectrum of drug development, commercialization, and strategic business development transactions. Mr. Ward most recently was the President and Chief Executive Officer of Radius Health, Inc.. Today the Company is po
12/27/17 - UPDATE Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer: Biopharmaceutical Industry Leader with Extensive Experience In Drug Development, Strategic Business Combinations and Commercialization to Lead The Company's St
Bob succeeds outgoing Chairman of the Board, Robert Heft, and current founder and Chief Executive Officer Dr. Mr. Ward brings to Eloxx more than 30 years of experience as a global biopharmaceutical industry leader with experience across the full spectrum of drug development, commercialization, and strategic business development transactions.
12/26/17 - Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
STAINES-UPON-THAMES, United Kingdom and ROCKVILLE, Md., Dec. 26, 2017/ PRNewswire/ Mallinckrodt plc, a leading global specialty pharmaceutical company, and Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, today announced that they have entered into an agreement under which Mallinckrodt will acquire Sucampo, including its commerc
12/25/17 - gel-e receives US FDA clearance to expand its bandage product line for Rx and OTC use
By a News Reporter-Staff News Editor at Pharma Business Week gel-e Inc., a privately held, clinical-stage medical device company, announces the 510 clearance of its adhesive bandage by the U.S. Food and Drug Administration for prescription and over-the-counter use. This new bandage clearance expands the Company's label to include the management o
12/24/17 - It's Raining FDA Approvals, SMMT Opens Wallet, AGRX Snubbed Yet Again
Shares of Agile Therapeutics Inc. plunged over 47% on Friday after the Company's investigational low-dose combined hormonal contraceptive patch Twirla was turned down by the FDA yet again. In its Complete Response Letter, the FDA has raised concerns of deficiencies relating to quality adhesion test methods, deficiencies in a facility of the Company
12/23/17 - U.S. health officials to target high-risk alternative remedies
WASHINGTON U.S. health officials plan to crack down on a growing number of unproven alternative remedies, focusing on products containing dangerous ingredients that have occasionally been linked to serious injury and death. The Food and Drug Administration issued a new proposal for regulating homeopathic medicines that have long been on the fringe
12/22/18 - Cosmos Holdings, Inc. Acquires Cosmofarm Ltd.
-Cosmos Holdings, Inc., an international pharmaceutical company, announced the closing of its acquisition of Cosmofarm Ltd, a privately held company located in Athens, Greece. We are excited to announce the closing of this acquisition and to have Cosmofarms talented team become part of Cosmos Holdings, Cosmos Holdings CEO Gregory Siokas commented.
12/22/17 - Bausch + Lomb Receives FDA Approval of LUMIFY? - The Only Over-The-Counter Eye Drop With Low-Dose Brimonidine For The Treatment Of Eye Redness
Bausch+ Lomb, a leading global eye health company and wholly owned subsidiary of Valeant Pharmaceuticals International, Inc., today announced that the U.S. Food and Drug Administration has approved LUMIFY? as the first and only over-the-counter eye drop developed with low-dose brimonidine tartrate for the treatment of ocular redness.
12/22/17 - Eloxx Pharmaceuticals Completes Acquisition Transaction with Sevion Therapeutics
Company to focus on advancing the clinical development of ELX-02, a disease- modifying therapy for genetic diseases caused by nonsense mutations WALTHAM, Mass., REHOVOT, Israel, and SAN DIEGO, Dec. 22, 2017 Eloxx Pharmaceuticals Ltd. and Sevion Therapeutics, Inc. today announced the two companies have completed their previously announced acquisit
12/22/17 - Eloxx Pharmaceuticals Completes Acquisition Transaction with Sevion Therapeutics: Company to focus on advancing the clinical development of ELX-02, a disease-modifying therapy for genetic diseases caused by nonsense mutations
WALTHAM, Mass., REHOVOT, Israel, and SAN DIEGO, 2017-12-22 14:45 CET. Eloxx Pharmaceuticals Ltd. and Sevion Therapeutics, Inc. today announced the two companies have completed their previously announced acquisition transaction effective as of December 19, 2017. The Company will be known as Eloxx Pharmaceuticals, Inc. following the completion of t
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415